WALTHAM, Mass.–(BUSINESS WIRE)–Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. This innovative test is the first of its kind to receive FDA clearance for direct quantitative measurement of free testosterone levels, marking a significant advancement in diagnostic capabilities for androgen disorders. Key features of the

BOSTON & SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore (the licensed territory). Pove is a recombinant fusion protein therapeutic and dual antagonist of BAFF (B cell activating factor) and

SHANGHAI & CAMBRIDGE, Mass. & BOSTON–(BUSINESS WIRE)–Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore (the licensed territory). Pove is a recombinant fusion protein therapeutic and dual antagonist of BAFF (B cell activating factor) and

DUBLIN–(BUSINESS WIRE)–The “Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) – Advances & Applications, 2025” report has been added to ResearchAndMarkets.com’s offering. MSCs are multipotent cells that have been referred to as mesenchymal stem cells, medicinal signaling cells, and mesenchymal stromal cells, reflecting their versatility and diverse applications. MSCs can differentiate into a variety of cell types, such as osteoblasts, chondrocytes, myocytes, and adipocytes. Their

FT. MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics’ Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time.

LONDON & NEW YORK–(BUSINESS WIRE)—- $CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (“ADS Warrant”) to purchase one

NASHVILLE, Tenn.–(BUSINESS WIRE)– #biohacking–Next Health debuts in Tennessee with its first Nashville location opening Jan. 20 in The Gulch, offering health optimization and longevity services.

PALO ALTO, Calif.–(BUSINESS WIRE)–Ronald McDonald House Charities Bay Area (RMHC Bay Area) is thrilled to announce the appointment of six dynamic new members to its Board of Directors. Each brings a unique mix of experience, passion, and commitment to the organization’s mission and programs that remove barriers, strengthen families and promote healing. The new board members, joining RMHC Bay Area, include: Chase Lyman, co-chief real estate officer at the Sobrato Organization and a long-time s